Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study for VE303, a potential first-in-class ...
Alligator Bioscience has announced positive outcomes from indirect treatment comparison studies, showing that mitazalimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback